Research Solutions (RSSS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Dec, 2025Executive summary
Total revenue for Q2 FY2025 was $11.9 million, up 15.5% year-over-year, driven by record organic platform deployments, customer expansion, and the Scite acquisition.
Platform revenue rose 47% to $4.6 million, now 39% of total revenue, with B2C and B2B segments both contributing to growth.
Annual recurring revenue (ARR) increased 23% to $19.1 million, with B2B ARR at $12.7 million and B2C ARR at $6.4 million.
Net loss was $2 million, or $0.07 per share, compared to a net loss of $54,000 in the prior year, mainly due to a $2.4 million provision for Scite earn-out.
Adjusted EBITDA improved to $963,000, up 202% year-over-year, reflecting improved operating performance excluding non-recurring items.
Financial highlights
Gross margin improved to 48.9%, up 540 basis points year-over-year, driven by a shift to higher-margin platform business.
Transaction revenue was $7.3 million, up 1.7% year-over-year, with modest growth mainly from the academic segment.
Operating expenses increased 16.8% year-over-year, mainly from higher sales, marketing, and technology costs associated with the Scite acquisition.
Cash and cash equivalents were $7.7 million at quarter end, with strong cash flow from operations of $1 million in the quarter.
For the six months ended December 31, 2024, total revenue was $24.0 million, up 17.6% year-over-year, with a net loss of $1.3 million.
Outlook and guidance
Expect continued strong performance in Q3 and Q4, with Q3 and Q4 typically being the strongest for profitability and cash flow.
Management expects continued growth from expanded platform deployments, customer base expansion, and integration of Scite and Resolute AI.
Anticipate increased sales and marketing investment in the next quarters, with CAC and CAC to LTV temporarily impacted but expected to normalize as bookings accelerate.
No material shift expected in SG&A expenses from Q2 levels.
No material changes to risk factors or forward-looking statements since the last annual report.
Latest events from Research Solutions
- ARR up 14% to $21.8M, net income $547K, and platform revenue up 14% amid margin gains.RSSS
Q2 202613 Feb 2026 - SaaS-driven growth accelerates as AI research tools boost revenue, margins, and market reach.RSSS
2024 Southwest IDEAS Conference3 Feb 2026 - SaaS-driven research platform sees 20%+ growth, expanding with AI and strategic M&A.RSSS
The 15th Annual East Coast IDEAS Conference3 Feb 2026 - AI-powered research platform drives SaaS growth, high retention, and unique content access.RSSS
15th Annual Midwest IDEAS Investor Conference23 Jan 2026 - Record revenue and ARR growth, strong margins, and robust cash flow despite acquisition charges.RSSS
Q4 202420 Jan 2026 - ARR up 60% to $17.6M, net income positive, and Platform revenue up 67% year-over-year.RSSS
Q1 202514 Jan 2026 - Record ARR, platform growth, and AI expansion drove higher profitability and cash flow.RSSS
Q3 202527 Dec 2025 - SaaS and AI-driven research platform achieves rapid growth, high margins, and strong retention.RSSS
Planet MicroCap Showcase: VEGAS 202523 Dec 2025 - Vertical SaaS and AI research platform firm files to raise up to $60M for growth and acquisitions.RSSS
Registration Filing16 Dec 2025